International Health

• CDC-PAHO Collaboration: Surveillance of Emerging/Reemerging Diseases in the Amazon and the Southern Cone Region
  Gabriel Schmunis, Pan American Health Organization, Washington, DC
• Protecting the Nation's Health in an Era of Globalization: CDC's Global Infectious Disease Strategy
  Scott Dowell, CDC, Atlanta, GA
• Update on the WHO Global Alert and Response Network
  Ray Arthur, WHO, Geneva, Switzerland

• Foot and Mouth Disease
  Christopher Bostock, Institute of Animal Health, Compton, United Kingdom
• Integrated Surveillance and Control of Emerging Foodborne Diseases—The Successful Danish Experience
  Henrik Wegener, Danish Zoonosis Institute, Denmark

• New Strategies on the Old Ideas: Malaria Control Without Insecticides and Community Participation in Aedes aegypti Control, Mexico's Experiences
  Jorge F. Méndez-Galván, Ministry of Health, Mexico City, Mexico
• Trypanosomiasis as a Reemerging Infection
  Anne Moore, CDC, Atlanta, GA

First Encounters with New Diseases: The Clinician's Perspective

• AIDS
  Michael Gottlieb, Los Angeles, CA
• Hantavirus Pulmonary Syndrome
  Bruce Tempest, Gallup, NM
• West Nile Virus Infection
  Deborah Asnis, Brooklyn, NY

Anthrax 2001: Lessons that Stunned Us

• Anthrax in the U.S. Postal System
  Michele Pearson, CDC, Atlanta, GA
• Cutaneous Anthrax in New York City
  Marcelle Layton, New York Department of Health, New York, NY
• Inhalation Anthrax in Florida
  Steve Wiersma, Florida Department of Health, Tallahassee, FL
• Inhalation Anthrax of Unknown Source
  James Hadler, Connecticut Department of Public Health, Hartford, CT

Emerging Issues in Healthcare Settings

• Controlling Antimicrobial Resistance
  Barry Farr, University of Virginia Hospital, Charlottesville, VA
• Patient Safety: Applying Industrial Quality Models in Healthcare Settings to Improve Outcomes
  Julie Gerberding, CDC, Atlanta, GA
• Prevention of Intravascular Catheter-Related Infections
  Leonard Mermel, Rhode Island Hospital, Providence, RI
• The Role of Healthcare Systems in Bioterrorism Preparedness
  Trish Perl, Johns Hopkins Hospital, Baltimore, MD

Pathogen Discovery

• Clusters of Clinical Syndromes in Patients with Unexplained Encephalitis
  Carol Glaser, California Department of Health Services, Berkeley, CA
• Proteomics and Pathogen Discovery
  Donald Hunt, University of Virginia, Charlottesville, VA
• The New Human Metapneumovirus
  Albert Osterhaus, University of Rotterdam, Rotterdam, The Netherlands
• Multiple Array Technology to Look for mRNA Patterns Associated with Disease and Pathogens
  David Relman, Stanford University, Stanford, CA

Preventing Infectious Disease Through Behavioral Change

• Bringing Dengue Prevention Down to Earth: Evaluation of a Head Start Project in Puerto Rico
  Carmen Pérez-Guerra, CDC, San Juan, PR
• Increasing Water Vessel Use in Kenya
  Philip Makutsa, CARE International in Kenya, Homa Bay, Kenya
• Sex Workers as Targets of and Agents for HIV/STI Prevention
  Rafael Mazin, Pan American Health Organization HCA/HCP, Washington, DC
• The Essential Role of Behavioral and Social Sciences in the Prevention of Emerging Infectious Diseases
  Emily Zielinski-Gutiérrez, CDC, Fort Collins, CO

The World and Its Moving Parts: Implications for Emerging Infectious Diseases

• Emerging Vectorborne Disease: The Case of Yellow Fever
  C.J. Peters, University of Texas, Medical Branch, Galveston, TX
• Global Migration and Emerging Infectious Diseases
  Daniele Grondin, International Organization for Migration, Geneva, Switzerland
• The Globalization of Our Food Supply: Implications for Emerging Infections
  Michael Osterholm, University of Minnesota Academic Health Center, Minneapolis, MN
• The World and Its Moving Parts: An Overview
  Martin Cetron, CDC, Atlanta, GA

Antimicrobial Resistance II

• Antimicrobial Resistance in Salmonella is Associated with Increased Hospitalization: NARMS 1996-2000
  J.K. Varma, CDC, Atlanta, GA
• Antimicrobial Resistance in Salmonella Serotype Typhimurium, R-Type ACSSuT, is Associated with Bacteremia: NARMS 1996-2000
  Kare Molbak, Statens Serum Institut, Copenhagen, Denmark
• Emerging Fluoroquinolone Resistance among Non-Typhoidal Salmonella in the United States: NARMS 1996-2000
  Shannon Rossiter, CDC, Atlanta, GA
• Prevalence of Salmonella spp. and Campylobacter spp. Following the Discontinued Use of Antimicrobial Growth Promoters in Broilers and Swine in Denmark
  Mary Evans, Danish Veterinary Institute, Copenhagen, Denmark
• Quinupristin/Dalfopristin-Resistant Enterococcus faecium Isolated from Human Stools, Retail Chicken, and Retail Pork: EIP Enterococci Project
  Kathryn Gay, CDC, Atlanta, GA
• Randomized Trial of Day Care Staff Education to Improve Parent Knowledge and Attitudes Regarding Appropriate Antibiotic Use
  Donita Croft, Wisconsin Division of Public Health and CDC, Madison, WI

Emerging Zoonoses II

• A Neighborhood Outbreak of Q Fever Linked to a Goat Ranch in California
  Michele Jay, California Department of Health Services, Sacramento, CA
• Clinical Management and Outcomes of Lyme Disease in Wisconsin
  Daniel O'Leary, CDC, Fort Collins, CO
• Emerging Rickettsioses of the Thai-Myanmar Border
  Philippe Parola, Harvard School of Public Health, Boston, MA
• Emerging Zoonoses: A Novel Epizootic of Skunks Infected with a Bat Variant of Rabies
  Mira Leslie, Arizona Department of Health Services, Phoenix, AZ
• Epidemiology of Raccoon and Skunk Rabies in the Eastern United States
  Marta Guerra, CDC, Atlanta, GA
• Q Fever in the United States: Experience of Infectious Disease Consultants and Comparison to National Reporting During 2000
  Jennifer McQuiston, CDC, Atlanta, GA

Foodborne and Waterborne Illness II

• Yersinia enterocolitica Surveillance in Minnesota
  Joni Scheftel, Minnesota Department of Health, Minneapolis, MN
• Epidemiology of Shiga Toxin-Producing Escherichia coli (STEC) Infections in Connecticut, February 1, 2000-January 31, 2001
  Q. Phan, Connecticut Department of Public Health, Hartford, CT
• Microbiologic Testing to Identify Shiga Toxin-Producing E. coli in HUS Patients: FoodNet 1997-2001
  C.R. Braden, CDC, Atlanta, GA
• Re-estimating the Global Burden of Typhoid Fever
  John Crump, CDC, Atlanta, GA
• Risk Factors for Sporadic Escherichia coli O157 Infections in the United States: A Case-Control Study in FoodNet Sites, 1999-2000
  M.H. Kennedy, CDC, Atlanta, GA
• Three Outbreaks of E. coli O157 Infections Due to Retail Ground Beef in Minnesota, 2000: Detection, Investigation, and Characteristics
  Ellen Swanson, Minnesota Department of Health, Minneapolis, MN

Prevention and Control Strategies

• Active Laboratory Surveillance in Massachusetts
  Bela Matyas, Massachusetts Department of Public Health, Jamaica Plain, MA
• An Evaluation of an Educational Videotape to Prevent Botulism among Alaska Natives
  Catherine Dentinger, CDC, Anchorage, AK
• Evidence of Effectiveness of Egg Quality Assurance Programs, Mandatory Refrigeration, and Traceback Investigations to Mitigate Egg-Associated Salmonella enteritidis Infections in the United States
  Gerald Mumma, CDC, Atlanta, GA
• Improving Influenza and Pneumococcal Vaccination Rates for People 65+ in Rhode Island through Coalition Building Efforts
  Thomas Bertrand, Rhode Island Department of Health, Providence, RI
• The Emergence of Serogroup Y Disease and the Epidemiology of Invasive Meningococcal Disease in Colorado, 1997-2001
  Lucinda Hammond, Colorado Department of Public Health and Environment, Denver, CO
• Transmission of the Main Viral Pathogens Causing Gastroenteritis, NLV, SLV, and Rotavirus
  Yvonne van Duynhoven, National Institute of Public Health and the Environment, Bilthoven, The Netherlands

Vectorborne Diseases II

• In vivo Sensitivity of Plasmodium falciparum to Chloroquine and Sulfadoxine/Pyrimethamine During an Outbreak of Malaria in Burundi, 2001
  François Dantoine, Epicentre, Paris, France
• A Greenhouse Study to Model Potential Field Use of Genetically Modified Bacterial Symbionts for Chagas' Disease Control
  Pritha Sen, CDC, Atlanta, GA
• Dengue Fever Outbreak in Hawaii—2001
  Paul Effler, State of Hawaii Department of Health, Honolulu, HI
• Ecological Niche Modeling and Differentiation of Populations of Triatoma Brasiliensis Neiva, 1911, the Most Important Chagas Disease Vector in Northeastern Brazil (Hemiptera, Reduviidae, Triatominae)
  Jane Costa, CDC, Atlanta, GA
• Re-introduction of Dengue 3 in Aragua, Venezuela: Clinical, Epidemiological and Laboratory Features of a New Outbreak
  Guillermo Comach, Lardidev-Biomed, Universidad de Carabobo, Maracay, Venezuela
• Risk Factors for Lyme Borreliosis: A German Case-Control Study
  Andrea Ammon, Robert Koch Institute, Berlin, Germany

Global Health and GIS

• A WHO Global Salm-Surv Retrospective Study Examining Salmonella Serotypes in South America, 2000: Dominance of Salmonella Serotype Enteritidis
  WHO Global Salm-Surv South America Working Group, Instituto INEI-ANLIS "Carlos G. Malbran", Buenos Aires, Argentina
• Investigation of Q Fever in Bosnia-Herzegovina, 2000: An Example of International Cooperation
  Jennifer McQuiston, CDC, Atlanta, GA
• Mapping of West Nile Virus Risk in the Northeast United States Using Multi-Temporal Meteorological Satellite Data
  P. Bryon Backenson, New York State Department of Health, Albany, NY
• Modeling Tuberculosis Dissemination in Harris County, Texas, 1995-1998, with Spatial Analysis and Geographic Information Systems (GIS)
  Matthew Stone, University of Texas-Houston, Houston, TX
• Recurrent Histoplasmosis Outbreaks in Acapulco, Mexico
  Yuri Roldán-Aragón, National Institute of Medical Science and Nutrition, Mexico City, Mexico

Influenza

• A DoD Global Influenza Surveillance Program
  Linda Canas, Brooks Air Force Base, San Antonio, TX
• Acute Respiratory Virus Surveillance in Cairo and Alexandria, Egypt, July 2000-June 2001
  Diaa Salman, U.S. Naval Medical Research Unit No 3., Cairo, Egypt
• Geographical Coherence of Influenza Epidemics in the U.S., France, and Australia: 1978-1998
  Cecile Viboud, INSERM U444, Paris cedex 12, France
• Influenza Surveillance in New York State, 1998-2001
  Marilyn Kacica, New York State Department of Health, Albany, NY
• PER.C6: A Human Designer Cell Line Providing a Pandemic-Proof Platform for the Manufacturing of Safe Influenza Vaccines
  Fons UytdeHaag, Crucell Holland BV, Leiden, The Netherlands
• Using CUSUM Techniques to Identify Influenza Outbreaks
  Michael Stoto, The Rand Corporation, Arlington, VA

Latebreakers II

• An Anthrax Outbreak Averted: Public Health Response to a Contaminated Envelope on Capitol Hill, Washington, DC, 2001
  V.P. Hsu, CDC, Atlanta, GA
• Bioterrorism 2001: Lessons Learned
  L.A. Cole, Rutgers University, Newark, NJ
• Importance of Bacillus anthracis Molecular Subtyping During the Recent Multi-State Bioterrorism-Associated Anthrax Outbreak in the United States
  A. Hoffmaster, CDC, Atlanta, GA
• Inhalational Anthrax—New York City, October-November 2001
  T.H. Holtz, New York City Department of Health, New York, NY
• Letters from Trenton: The Anthrax Investigation at the Source, New Jersey, 2001
  J. Reefhuis, CDC, Atlanta, GA
• Rapid Adaptation of a Serologic Assay for the Bioterrorism-Related Anthrax Outbreak—October-December, 2001
  C.M. Greene, CDC, Atlanta, GA

Molecular Diagnostics and Epidemiology II

• Detection of La Crosse Virus in Cerebrospinal Fluid and Tissues by Reverse Transcription-Polymerase Chain Reaction
  Brett Slater, New York State Department of Health, Slingerlands, NY
• Determination of Allelic Diversity in the mec Operon of Methicillin-Resistant Staphylococcus aureus in Wisconsin
  Sanjay Shukla, Marshfield Medical Research Foundation, Marshfield, WI
• Development and Evaluation of PCR-Based Diagnostics for Identification of Salmonella O Antigens Based on the rfb Locus
  Collette Fitzgerald, CDC, Atlanta, GA
• Molecular Characterization of a Multiresistant Strain of Salmonella enterica serotype Typhimurium DT204b Responsible for an International Outbreak of Salmonellosis
  E.J. Threlfall, Central Public Health Laboratory, London, United Kingdom
• PulseNet Experience: Software Changes and Improvements to Online E. coli National Database
  Susan Hunter, CDC, Atlanta, GA
• Real-time Fluorescence PCR Assays for the Detection and Characterization of Heat-Labile and Heat-Stable Enterotoxin Genes from Enterotoxigenic Escherichia coli
  Nancy Strockbine, CDC, Atlanta, GA

Surveillance and Information Systems

• Analysis of a Health Indicator Surveillance System: Its Ability to Detect Annual Influenza Activity for the 1999-2000 and 2000-2001 Seasons Compared to Traditional Surveillance Systems
  Ji-Eun Lee, Department of Defense Global Emerging Infections System, Silver Spring, MD
• Foodborne Viruses in Europe: Web-Based Technologies for Investigation of Transnational Outbreaks of Viral Gastroenteritis
  Ben Lopman, Public Health Laboratory Service, London, United Kingdom
• Lessons Learned from Implementing Electronic Laboratory Reporting, New York State
  Perry Smith, New York State Department of Health, Albany, NY
• Lyme Disease Incidence in Wisconsin: A Comparison of State Reported Rates with Rates from a Population-Based Cohort
  Allison Naleway, Marshfield Medical Research Foundation, Marshfield, WI
• Outbreak Surveillance: An Important Tool for Controlling Communicable Diseases
  Michael Baker, ESR, Wellington, New Zealand
• Surveillance for Patients with Acute Febrile Illness in Egypt
  Salma Afifi, U.S. Naval Medical Research Unit No. 3, Cairo, Egypt